0001209191-22-062281.txt : 20221220
0001209191-22-062281.hdr.sgml : 20221220
20221220205832
ACCESSION NUMBER: 0001209191-22-062281
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221220
DATE AS OF CHANGE: 20221220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kenny Pauline
CENTRAL INDEX KEY: 0001958090
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 221476371
MAIL ADDRESS:
STREET 1: C/O KINETA, INC.
STREET 2: 219 TERRY AVE. N., SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KINETA, INC./DE
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: (206) 378-0400
MAIL ADDRESS:
STREET 1: 219 TERRY AVE. N.
STREET 2: SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140813
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-16
0
0001445283
KINETA, INC./DE
KA
0001958090
Kenny Pauline
C/O KINETA, INC.
219 TERRY AVE. N., SUITE 300
SEATTLE
WA
98109
0
1
0
0
General Counsel
Common Stock
2022-12-16
4
A
0
10635
A
10635
D
Common Stock
2022-12-16
4
A
0
5042
A
15677
D
Common Stock
2022-12-16
4
A
0
3440
A
19117
D
Stock Option (Right to Buy)
12.11
2022-12-16
4
A
0
619
A
2023-12-31
Common Stock
619
619
D
Stock Option (Right to Buy)
23.11
2022-12-16
4
A
0
5159
A
2027-06-29
Common Stock
5159
5159
D
Stock Option (Right to Buy)
27.03
2022-12-16
4
A
0
11007
A
2032-05-30
Common Stock
11007
11007
D
Stock Option (Right to Buy)
23.25
2022-12-16
4
A
0
5228
A
2028-11-09
Common Stock
5228
5228
D
Stock Option (Right to Buy)
26.16
2022-12-16
4
A
0
3440
A
2031-05-26
Common Stock
3440
3440
D
Stock Option (Right to Buy)
23.25
2022-12-16
4
A
0
19952
A
2028-03-19
Common Stock
19952
19952
D
Received in connection with the Issuer's merger (the "Merger") with Kineta, Inc. ("Legacy Kineta") in accordance with the terms of the Agreement and Plan of Merger dated as of June 5, 2022, as amended on December 5, 2022 (the "Merger Agreement"), by and among the Issuer (f/k/a Yumanity Therapeutics, Inc.), Yacht Merger Sub, Inc. and Legacy Kineta. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Kineta common stock was entitled to receive 0.0688 shares of Common Stock. The Merger closed on December 16, 2022.
Represents shares of Common Stock underlying time-based restricted stock unit awards ("RSUs"). The RSUs will vest in full on June 14, 2023, subject to the continuing employment of the Reporting Person on such vesting date.
Received in connection with the Merger in exchange for 73,291 shares of common stock underlying Legacy Kineta RSUs.
Represents shares of Common Stock underlying a time-based RSU. The RSU will vest in full on March 16, 2023, subject to the continuing employment of the Reporting Person on such vesting date.
Received in connection with the Merger in exchange for 50,000 shares of common stock underlying a Legacy Kineta RSU.
The stock option is fully vested and exercisable.
Received in connection with the Merger in exchange for options to acquire 9,000 shares of Legacy Kineta common stock for $0.8333 per share.
Received in connection with the Merger in exchange for options to acquire 75,000 shares of Legacy Kineta common stock for $1.59 per share.
The stock option vested as to 1/3 of the total number of shares on May 31, 2022, and an additional 1/3 of the total number of shares will vest on each yearly anniversary thereafter, until such time as the stock option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Received in connection with the Merger in exchange for options to acquire 160,000 shares of Legacy Kineta common stock for $1.86 per share.
Received in connection with the Merger in exchange for options to acquire 76,000 shares of Legacy Kineta common stock for $1.60 per share.
The stock option vested as to 1/3 of the total number of shares on May 27, 2021, an additional 1/3 of the total number of shares vested on May 27, 2022, and the remaining 1/3 of the total number of shares will vest on May 27, 2023, subject to the continuing employment of the Reporting Person on each vesting date.
Received in connection with the Merger in exchange for options to acquire 50,000 shares of Legacy Kineta common stock for $1.80 per share.
Received in connection with the Merger in exchange for options to acquire 290,000 shares of Legacy Kineta common stock for $1.60 per share.
/s/ Pauline Kenny, as Attorney-in-Fact
2022-12-20